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344Background: Primary pulmonary vein stenosis is often associated with relentless restenosis and early death.
During the last 2 decades, we have developed a sutureless repair to improve prognosis.
Methods:Hospital records for patients undergoing repair of primary pulmonary vein stenosis from 1989 to 2008
were reviewed. Pulmonary vein stenosis was quantified with a pulmonary vein stenosis score. Survival was
determined by Kaplan–Meier analysis.
Results: Twenty-three patients underwent surgical repair. Mean ages at diagnosis and index repair were 23.3
45.6 and 24.1 40.9 months, respectively. Systemic or suprasystemic pulmonary artery pressures were present
in 13 of 18 patients (72%). Seven (31%) had single-ventricle circulation. A sutureless technique was used in 19
of 23 cases (83%). Other types of repair were used in 4 of 23 (17%). There were 11 recorded deaths (47%).
Survivals were 64%, 47%, and 31% at 1, 5, and 10 years, respectively. Five patients (22%) required 1 reinter-
vention. Surgical repair significantly reduced the total pulmonary vein stenosis score (5.6  2.10 before repair,
2.6  2.72 after repair, P ¼ .0057). The preoperative pulmonary vein stenosis score was the only independent
predictor of mortality (hazard ratio, 1.732;P<.01). A preoperative pulmonary vein stenosis score of greater than
4 was a poor prognostic indicator (area under the curve, 0.83).
Conclusions:Mortality and restenosis rates remained high despite the adoption of a sutureless technique. A pre-
operative pulmonary vein stenosis score of greater than 4 was a strong predictor of poor prognosis. (J Thorac
Cardiovasc Surg 2011;142:344-50)Pulmonary vein stenosis (PVS) with normally related pul-
monary veins is a rare anomaly, and its presentation can
vary in severity between a mild discrete stenosis at the ve-
noatrial junction to long narrow stenotic segments of the
pulmonary veins to vein atresia. The involvement of 1 or
more veins can produce severe arterial pulmonary hyperten-
sion and right ventricular failure, which often leads to death
despite repair.1 Traditional surgical pulmonary venoplasties
and percutaneous interventions have yielded disappointing
results because of high incidences of restenosis and persis-
tent pulmonary hypertension.2-5
So-called sutureless techniques have been previously de-
scribed for repair of recurrent stenosis after repair of total
anomalous pulmonary venous connection4-6 but have not
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The Journal of Thoracic and Cardiovascular Surgthe poor prognosis for patients with primary PVS, we
sought to review our surgical experience in the treatment
of primary PVS. Our objectives were to evaluate the use
of the PVS score as previously described4 as an estimate
of the severity of disease, to evaluate the impact of the su-
tureless technique on surgical outcomes, and to identify
risk factors for surgical success and failure in the treatment
of primary PVS.
MATERIALS AND METHODS
Population
After approval from the research ethics board at the Hospital for Sick
Children, we searched our Cardiovascular Surgery Database between
September 1989 and October 2008 and identified 23 patients with primary
PVS. Patients with previous pulmonary vein surgery (eg, repair of anoma-
lous pulmonary venous drainage) were excluded. Hospital records were
reviewed, and follow-up data were obtained by contacting the treating
cardiologists. Patient characteristics are shown in Table 1.
Therewere 9 premature neonates (39.1%), with amedian gestational age
of 32 4 weeks (range, 25–36 weeks). The mean age at diagnosis was 23.3
 45.6 months (range, 0.1–183.3 months), and the mean age at first surgical
repair was 24.1  40.9 months (range, 1.1–162.4 months), with a mean
weight of 10.05  11.6 kg (range, 2.3–49.5 kg). Thirteen patients had sys-
temic or suprasystemic pulmonary pressures at the time of diagnosis.
All patients had associated cardiac anomalies. Seven patients (30.4%)
had a univentricular circulation. One patient had scimitar syndrome in
association with primary stenosis of left-side pulmonary veins. A second
patient had cor triatriatum in association with bilateral long stenosis of
left pulmonary veins. A third patient had a supramitral membrane. Six of
the 7 patients with univentricular circulation had some form of palliation
at the time of the index operation. Surgical procedures performed beforeery c August 2011
Abbreviation and Acronym
PVS ¼ pulmonary vein stenosis
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patent ductus arteriosus ligations. One patient had undergone emergency
right ventricular repair for acute perforation caused by a diagnostic
catheterization.
PVS Score
PVS score has been previously proposed as a subjective measure of
disease burden.5 To calculate the score, each pulmonary vein was assessed
independently, and the degree of stenosis was evaluated on the basis of
2-dimensional description and Doppler interrogation. The diameter of
the veins (expressed in millimeters) was measured on 2-dimensional imag-
ing. Flow velocities were recorded at the venoatrial junction to provide
a pressure gradient. Diffusely narrow veins were also identified. Each
vein was assigned a number between 0 and 3. A score of 0 indicated the
absence of stenosis or hypoplasia and unobstructed, biphasic blood flow.
A score of 1 indicated mild to moderate stenosis, with a minimum pulmo-
nary vein diameter of about 3 to 4 mm and a pressure gradient measured at
the venoatrial junction of less than 6 mm Hg. A score of 2 indicated severe
stenosis with a pinpoint ostium and a pressure gradient greater than 7 mm
Hg. A score of 3 indicated occlusion or atresia of the pulmonary vein.
Scores were calculated after every echocardiographic examination per-
formed. PVS scores were validated by 1 observer (A.A.A.) who indepen-
dently reviewed a sample of 113 vein images. Their observations were
weighted against the echocardiographic reports completed by experienced
cardiologists at our institution. Complete concordance between observers
was found in 97% of the samples. Scores obtained for each vein were
summed to obtain the total PVS score.
Operative reports were reviewed and consistently mentioned the operat-
ing surgeon’s observations stating the diameter of the vein at the venoatrial
junction or the presence of diffuse vein hypoplasia. Surgical and postmor-
tem histologic sampling, venoangiography, magnetic resonance angiogra-
phy, and computed tomographic scan were inconsistently performed and
therefore not used as primary sources of scoring data but rather used to
strengthen the echocardiographic analysis (Figure 1).
Statistical Analysis
A statistical software package (SAS version 9.1; SAS Institute, Inc,
Cary, NC) was used for all statistical analyses. Categoric data were summa-
rized as frequencies and percentages, and continuous variables were sum-
marized as mean, medians, and SD. Categoric variables were compared
with the c2 test, and continuous variables were compared with the student
t test. Kaplan–Meier statistics were used to compare time to death in differ-
ent subgroups. Log-rank test with a significance level less than .05 was used
to compare survival curves. Stepwise proportional hazard modeling was
used to identify possible independent predictors of mortality. Analysis of
variance was used to compare PVS scores before and after the repair. Pre-
dictive accuracy for the obtained PVS score value was assessed by calcu-
lating the area under the receiver operating characteristics curve, and
model calibrations and fit were assessed with Hosmer–Lemeshow
goodness-of-fit statistics. Longitudinal data analyses of all echocardio-
graphic data were performed to show the averaged trend over time of
PVS score.RESULTS
Nineteen of 23 patients (83%) underwent repair with
a sutureless technique. Among these 19 patients, 12The Journal of Thoracic and Ca(52.1%) underwent repairs on the left side, 6 (26%) under-
went bilateral repairs, and 1 (4.3%) underwent repair of
the veins on the right side only. Of the remaining 4 patients,
3 (13%) underwent patch venoplasty and 1 (4.3%) under-
went bilateral stent insertion.
Operative data are shown in Table 2. Deep hypothermic
circulatory arrest was used in 6 cases, with a mean duration
of 26.5 16.5 minutes. Eleven patients (47.8%) underwent
additional procedures. The mean hospital stay for the entire
cohort was 52.95  87.85 days (range, 2–378 days).
Overall survivals for the whole cohort were 64% at 1
year, 47% at 5 years, and 31% at 10 years (Figure 2).
The mean survival was 5.5  1.02 years (range 1 day–9.7
years). Most deaths occurred during the index hospitaliza-
tion. The mean interval to last follow-up was 40.2  42.2
months (range, 0.1–156) months.
Among the 11 patients who died, 6 (55%) had no relief of
PVS and pulmonary hypertension at first repair, 4 (36%)
had initial relief of the stenosis but then had restenosis
that was clinically significant, and 1 (9%) died of irrevers-
ible pulmonary hypertension and lung infection despite sig-
nificant intraoperative reduction of the PVS score. Among
those who underwent repair without the sutureless tech-
nique, only 1 was alive at last follow-up.
Three patients (27%) underwent at least 1 reintervention.
One of these patients had undergone repair without the
sutureless technique. The other 2 patients underwent
reoperation twice; both underwent extension of the previous
sutureless repairs and subsequent percutaneous stenting.
All reinterventions were unsuccessful in relieving the
stenosis.
Among the 12 patients who survived to most recent
follow-up, 6 patients (50%) had significant relief of the ini-
tial stenosis that persisted to the most recent echocardio-
graphic examination. In contrast, in 3 patients (25%)
there was a progressive increase in PVS score. Finally, in
3 patients (25%) surgical repair failed to achieve a signifi-
cant reduction in the PVS score. These patients were de-
scribed in the operative report as having diffusely narrow
pulmonary veins, with internal diameter less than 3 mm.
As noted previously, 2 patients underwent reoperative su-
tureless repair. In both cases, the surgical anastomosis was
brought beyond the pericardium into the lung hilum to reach
the intraparenchymal portion of the veins, with a successful
result in 1 case and persistent mild stenosis at follow-up in
the other.
Although the clinical and functional statuses of survivors
were not investigated in this study, no patients at the time of
review had undergone lung transplant.
Statistical Analysis
The following variables were used to predict mortality by
stepwise proportional hazard analysis: sex, prematurity,
weight at the time of repair, preoperative PVS scorerdiovascular Surgery c Volume 142, Number 2 345
FIGURE 1. Summary of pulmonary vein stenosis score criteria. Diagnosis of pulmonary vein stenosis and consequent scoring were based primarily on
echocardiographic (Echo) observations. Preoperative 2-dimensional (2D) and Doppler data correlated with intraoperative macroscopic findings reported
by surgeon at time of repair. Postmortem specimens obtained in 5 patients (right column) showed normal venous anatomy in veins previously scored as
normal (score 0), mild degree of intimal hyperplasia in veins scored as mild to moderately occluded (score 1), near occlusion of vein with severe degree
of hyperplasia in veins scored as severe (score 2), and complete occlusion in veins previously scored 3.
TABLE 1. Patient characteristics
Subject Sex
Premature
(gestational wk)
Age at repair
(mo)
Weight
(kg)
Pulmonary
pressure Associated cardiac defects
Previous
operations
Status at
follow-up
1 F No 9.4 5.3 — VSD, PDA None Dead
2 F No 10.7 6.93 Systemic ASD None Dead
3 M No 17.4 10.5 Subsystemic HLHS BCPS Alive
4 M No 50.4 16.3 — TGA, tricuspid atresia Norwood Alive
5 F Yes (25) 6.1 5.5 Suprasystemic PFO, PDA None Alive
6 M No 131.8 49.5 — DORV, mitral atresia BCPS Alive
7 M No 34.8 14 Subsystemic TGA, coarctation, tricuspid
atresia
BCPS Alive
8 M No 7.3 7.1 Subsystemic ASD, VSD, PDA None Dead
9 M Yes (28) 10.2 6.77 — PFO, BAV None Alive
10 M Yes (26) 31.4 10 Subsystemic PFO, PDA None Alive
11 F Yes (32) 2.1 3.1 Suprasystemic ASD None Dead
12 M Yes (32) 4.3 4.5 Suprasystemic ASD, VSD PDA ligation Dead
13 M No 10.5 7.28 Suprasystemic ASD, scimitar syndrome None Alive
14 F Yes (27) 9 6.45 Subsystemic ASD None Alive
15 M No 19.8 9.5 — HLHS BCPS Alive
16 F No 1.7 4.4 Systemic ASD None Dead
17 M Yes (34) 6.2 2.3 Suprasystemic ASD, PDA None Dead
18 F Yes (34) 16.7 5.5 Suprasystemic PFO, VSD, ASD VSD closure Dead
19 M Yes (36) 2.8 2.8 Suprasystemic ASD, PDA None Dead
20 M No 1.1 3.8 Suprasystemic PFO, TR, PDA, RVP Alive
21 F No 10 5.5 Systemic VSD, cor triatriatum VSD closure Alive
22 F No 8.1 4.04 Systemic VSD, PA, cor triatriatum,
Ebstein anomaly
PDA closure Dead
23 M No 162.4 40.2 Subsystemic VSD, TGA, PS, mitral atresia BCPS Dead
VSD, Ventricular septal defect; PDA, patent ductus arteriosus; ASD, atrial septal defect;HLHS, hypoplastic left heart syndrome; BCPS, bidirectional cavopulmonary shunt; TGA,
transposition of the great arteries; PFO, patent foramen ovale; DORV, double-outlet right ventricle; BAV, bicuspid aortic valve; TR, tricuspid regurgitation; RVP, right ventricu-
loplasty; PA, pulmonary atresia; PS, pulmonary stenosis.
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TABLE 2. Type of repair, associated procedures, and operative data
Variable Value
Type of repair (no.)
Left-side sutureless repair 12 (52.1%)
Bilateral sutureless repair 6 (26%)
Venoplasty 3 (13%)
Right-side sutureless repair 1 (4.3%)
Bilateral stent 1 (4.3%)
Total 23 (100%)
Associated procedures (no.)
Atrial septal defect closure 4 (17.3%)
Ventricular septal defect closure 3 (13%)
Pulmonary arterial plasty 2 (8.6%)
Ventricular septal defect closure, atrial septectomy 1 (4.3%)
Right ventricular outflow tract plasty 1 (4.3%)
Total 11 (47.8%)
Operative data (median  SD)
Cardiopulmonary bypass time (min) 107.5  30.6
Crossclamp time (min) 63  26.6
Deep hypothermic circulatory arrest time (min) 26.5  16.5
Hospital stay (d) 52.95  87.85
FIGURE 2. Survival distribution for entire cohort after primary repair of
pulmonary vein stenosis.
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circulation, type of primary surgical repair, associated sur-
gical procedures, and use of deep hypothermic circulatory
arrest. Only the preoperative PVS score was found to be a
significant independent predictor of mortality, with a hazard
ratio of 1.732 (P<.01).
PVS Score Analysis
The preoperative PVS scores for the entire cohort were
5.6  2.1 before repair and 2.6  2.7 immediately after re-
pair (P ¼ .0057), suggesting that the surgical procedures
achieved the immediate surgical objective in most cases.
The mean scores recorded at 1 month (2.8  3.2), 3 months
(3.1  3.0), and 6 months (3.6  3.4), however, although
lower than the preoperative scores, seem to indicate
a time-related progressive increase in the severity of PVS,
culminating at 6 months when most deaths occurred.
The low scores recorded at 12 months (2.9  3.5) and at
last follow-up (2.1 2.5) may indicate overall lower preop-
erative scores before and after surgery among the selected
group of patients who survived to follow-up (Figure 3).
Scores were then stratified by survival at 12 months to
assess the efficacy of surgery for patients with different pre-
operative scores. Preoperative scores were significantly
higher in the early death group than in the group of those
who survived to follow-up (7  1.92 vs 4.4  1.51,
P ¼ .0015), indicating that nonsurvivors had greater preop-
erative severity of PVS. Surgery was associated with trend
toward reduced differences in the perioperative scores when
comparing the groups (3.5  3. 5 vs 1.6  2.1, P ¼ .1036).
At 1 month in the postoperative period, however, the PVS
scores showed a marked discrepancy (with greater severity
in the nonsurvivors). This discrepancy continued up to 12The Journal of Thoracic and Camonths, suggesting that early restenosis (rather than unsuc-
cessful repair) is among the causes of early death (Table 3).
In light of the strong association between preoperative
PVS score and overall survival, we evaluated the PVS score
with the best predictive value by calculating the area under
the receiver operating characteristic curves for all possible
preoperative scores (0 to 12). A PVS score of greater than
4 had the best predictive accuracy (area under the curve
0.83) for postoperative mortality.
We then performed a longitudinal data analysis that used
all PVS scores recorded before, at the time of, and after sur-
gery in an attempt to describe the long-term behavior of the
disease (Figure 4). Scores were plotted in trend lines for
every patient, and the mean values were calculated and
stratified into 2 groups according to preoperative value.
Patients with a preoperative score greater than 4 continued
to have scores that were consistently high after the repair. In
contrast, patients with a preoperative score less than 4 had
a temporary respite, with a decline in PVS score followed
by a long-term trend toward restenosis at 5 years.Pathology Specimens
Pathology specimens were collected from 6 patients, in 2
cases at the time of autopsy. In the remaining 4 cases, spec-
imens were collected and analyzed at the time of primary
repair. All specimens were analyzed independently by 2 pa-
thologists (D.G.P., G.J.W.) and were given a score that was
based on the same criteria used to assess the veins during re-
pair by the operating surgeon. In patient 1, macroscopic and
microscopic analysis of the autopsy specimen confirmed the
PVS score assigned before death. The pathologic findings
from the lung biopsy samples also confirmed severe venous
pulmonary hypertension with lung hemorrhage, which was
diagnosed at the time of death. Pulmonary arteries showed
only mild hypertensive changes. Patient 2 was a preterm in-
fant who had undergone operation at the age of 7 months,
when pulmonary hypertension and PVS became prominent.rdiovascular Surgery c Volume 142, Number 2 347
FIGURE 3. Longitudinal data analysis of mean pulmonary vein stenosis scores for patients, stratified by preoperative pulmonary vein stenosis score. Scores
were collected from all echocardiographic examinations on record from the time of first diagnosis (0 on x-axis) to examination at time of last follow-up.
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degree of stenosis of the individual veins, the patient was
discharged to home but died 3 months later of respiratory
syncytial virus infection. The left-side veins revealed an un-
obstructed confluence draining into the left atrium.Mild hy-
pertensive changes on both venous and arterial sides were
also noted. In the remaining 6 patients, various degrees of
hypertensive changes and PVS were demonstrated, and
the pulmonary vein specimens showed degrees of stenosis
that were consistent with the echocardiographically based
PVS score.
DISCUSSION
Primary PVS is rare, accounting for only 0.4% to 0.6% of
specimens reported from large registries and cardiovascular
surgical series.7-9 The clinical presentation can vary from
discrete stenosis at the venoatrial junction to diffusely
narrow vessels, intraparenchymal stenosis, and vein
atresia.10-12 Other cardiac defects are often seen in
association with PVS, including ventricular septal defects,
atrial septal defects or patent ductus arteriosus, tricuspid
atresia, Ebstein anomaly, tetralogy of Fallot, scimitar
syndrome, cor triatriatum, and univentricular circulations.1,13
The clinical presentation varies according to the degree of
involvement of the single veins and the number of veins af-
fected.14 Although the severe stenosis of 1 vein or a low
grade of stenosis in more than 1 vein may go undetected
for years,15 severe stenosis of both veins unilaterally is nor-
mally clinically significant because of the consequent venti-
lation–perfusion mismatch in the involved lung. WhenTABLE 3. Pulmonary vein stenosis scores stratified by outcome
Preoperative At repair 1 mo
Survivors 4.4  1.51 1.6  2.05 1.5  1.88
Nonsurvivors 7  1.92 3.5  3.45 4.3  4.0
P value .0015 .1036 .0714
348 The Journal of Thoracic and Cardiovascular Surgsevere disease involves the veins on both sides, the prognosis
is poor and life expectancy rarely exceeds 12 months.16,17
Since the first reported repair by Kawashima and
colleagues,18-20 a variety of surgical techniques, both
percutaneous and surgical, have been adopted to relieve
obstruction, with minimal success related to restenosis and
poor survival associated with persistent pulmonary
hypertension. The sutureless technique is designed to limit
the degree of reactive postoperative intimal proliferation
by avoiding contact with the vein wall. A few authors,
however, including our group, have described a sutureless
technique to repair PVS after repair of total anomalous
pulmonary venous connection, showing improved survival
and reduced need for reinterventions.4,6
Since 1998, all patients with a diagnosis of PVS (either
primary or secondary) have undergone repair at our institu-
tion with the sutureless technique. The technique includes
the initial complete resection of the stenotic portions and
the incision of the veins retrogradely into their intraparen-
chymal portion. The atrial wall is then directly anastomosed
to the pericardium, allowing the free egress of blood from
the lungs into the left atrium.
This report presents our experience with this procedure
applied to patients with primary PVS. Mortality was as
high as 47% for the whole cohort and remained high at
42% even when we excluded those 4 patients who under-
went the initial repair with nonsutureless techniques. We
found that at least 1 postoperative reintervention was re-
quired in 22% of the patients, and multiple interventions
were required in 10%. The high overall mortality recorded3 mo 6 mo 12 mo At follow-up
1.8  1.89 2.0  2.10 2.2  2.83 2.0  2.53
5.4  3.35 7.4  3.13 6.5  6.36 —
.0307 .0147 .5154
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FIGURE 4. A and B, Vein biopsy specimens from patient at time of repair. There is severe obstruction caused by fibrointimal proliferation in A and nearly
normal architecture in B. C and D, Patient with severe bilateral stenosis and suprasystemic pulmonary hypertension. Venoatrial junction shows marked neo-
intimal proliferation (C), and lung biopsy specimen shows grade 3 hypertensive changes. E, Patient operated on at age 10 months for scimitar syndrome and
left-side pulmonary vein stenosis with suprasystemic pulmonary pressure (total pulmonary vein stenosis score of 10). Section shows complete occlusion of
vein by fibroelastic tissue and maintained vein architecture (elastica still seen). Abundance of collagen (yellow brown) and elastic fibers (black) indicates
longevity of lesion. F, Patient with total pulmonary vein stenosis score of 8 and suprasystemic pulmonary pressures was operated on at 9 weeks. Left side
venoatrial junction shows abundant ground substance (blue green) andmyofibroblasts. Collagen and elastic fibers are sparse, indicating recent lesion (Movat
pentachrome stain).
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groups that have adopted the sutureless technique2 for
primary PVS.
Our logistic regression analysis showed that need for
recurrent interventions, univentricular circulation, the tech-
nique used for repair, and prematurity were not independent
risk factors for death,which is in contrast to other reports1,21;
however, our failure to identify these variables as risk factors
may be a limitation of the relatively small size of this cohort.
We did identify preoperative PVS score as an independent
risk factor for mortality, and this is consistent with the
initial report on use of the PVS score by Yun and
associates.4 In this analysis, we were able to refine the prog-
nostic value of the PVS score by identifying a threshold of
greater than 4 as a strong predictor of mortality.
When we used the PVS score as a marker for the behavior
of the disease, we observed that surgery was generally suc-The Journal of Thoracic and Cacessful in relieving the stenosis in most patients, but those
patients with high preoperative scores had an important
trend toward severe early restenosis. It is troubling to note
that survivors after 5 to 10 years still have a trend toward
late restenosis. The clinical significance of this observation
is still unexplored, but it may provide some insight into
the biologic factors that mediate late restenosis among
survivors.
Sadr and colleagues3 reviewed the histologic specimens
from 10 patients with the diagnosis of primary congenital
PVS. They found abnormal intimal spindle cell prolifera-
tion together with excessive production of loose matrix
and hypothesized that the restenosis process is due to an
inherent hyperproliferative process, rather than to inflam-
mation, thrombosis, or fibrosis. They also identified the pro-
liferating cell as a myofibroblast type cell.3 Our pathology
specimens confirmed some of those findings.rdiovascular Surgery c Volume 142, Number 2 349
Congenital Heart Disease Viola et al
C
H
DYamaki’s group22,23 has investigated the effects of PVS
on the lung vasculature in clinical models. Their work
suggests that the early presence of obstruction leads to
hypoplasia of the pulmonary arteries, which show small
diameters and medial thickening in the presence of
significant hypertension. They also showed how these
changes are potentially reversible if the obstruction is
relieved.22,23 In our series, we could demonstrate only
mild intimal proliferation in lung veins and mild
hypertensive changes in the pulmonary arteries of patients
with successful relief of the stenosis.
In subsequent animal studies, Endo and coworkers24
showed that even unilateral obstruction induces medial
thickening in both lungs, possibly as a result of reciprocal
regulatory mechanisms between the lungs. These observa-
tions could explain the poor clinical responses of some
patients to surgical repair and the apparent progression of
the disease even when the initial repair seems successful.
In addition, it could explain the similar outcomes in patients
with unilateral and bilateral obstruction in our series.
Study Limitations
This is among the largest series published on repair of
primary PVS, with a long follow-up of 13 years. The sample
size is still small, however, and this represents an important
limitation of the study.
In this study we hypothesized that directing the analysis
to the group of patients with the highest likelihood of reste-
nosis (the primary PVS group) would increase the likeli-
hood of detecting a benefit from the adoption of
a sutureless technique. The overall poor survival does not
support the hypothesis that the sutureless technique is
a superior surgical strategy in patients with primary PVS.
Another important limitation of this study is that the PVS
score relies on retrospective data derived primarily from
echocardiography. Although intraoperative and pathologic
findings seems to support the echocardiographic data,
a thorough validation is necessary to its broader application,
possibly with a more consistent correlation with angiogra-
phy, magnetic resonance angiography, and computed tomo-
graphic scan.
CONCLUSIONS
Primary PVS remains associated with high mortality
despite surgical repair. The use of the sutureless technique
is not universally effective in avoiding restenosis and reduce
fatal pulmonary hypertension, but in the subset of patients
with low preoperative PVS scores it is associated with
satisfactory survival and with a significant intraoperative
decrease in the PVS score. Use of a preoperative score of
greater than 4 as a predictor of mortality may provide useful
prognostic information to guide decision making in clinical
practice.350 The Journal of Thoracic and Cardiovascular SurgReferences
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